BioLineRx (BLRX) Institutional Ownership $2.96 -0.01 (-0.17%) Closing price 03:57 PM EasternExtended Trading$2.94 -0.02 (-0.68%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for BioLineRx (NASDAQ:BLRX)CurrentInstitutional OwnershipPercentage1.56%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$30.68MNumber ofInstitutional Sellers(last 12 months)0 Get BLRX Insider Trade Alerts Want to know when executives and insiders are buying or selling BioLineRx stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BLRX Institutional Buying and Selling by Quarter Remove Ads BioLineRx Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/12/2025Highbridge Capital Management LLC1,010,012$215K0.0%N/A50.501% 11/1/2024Atria Investments Inc133,974$72K0.0%+27.9%0.168% 8/22/2024PVG Asset Management Corp123,580$70K0.3%N/A0.155% 8/15/2024CVI Holdings LLC815,683$462K0.4%N/A1.020% 3/12/2024PVG Asset Management Corp61,840$97K0.5%N/A0.085% 2/8/2024NorthRock Partners LLC17,125$27K0.0%N/A0.024% 12/1/2023B. Riley Wealth Advisors Inc.21,300$39K0.0%+88.5%0.029% 11/21/2023Allen Mooney & Barnes Investment Advisors LLC25,000$46K0.0%N/A0.035% 11/13/2023Rathbones Group PLC39,820$72K0.0%N/A0.065% 11/8/2023Values First Advisors Inc.48,348$88K0.1%N/A0.079% Get the Latest News and Ratings for BLRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioLineRx and its competitors with MarketBeat's FREE daily newsletter. 10/11/2023Geneos Wealth Management Inc.40,500$74K0.0%+72.3%0.066% 7/31/2023PVG Asset Management Corp61,840$99K0.4%-52.0%0.101% 5/16/2023Altium Capital Management LP2,279,657$2.02M1.1%-26.5%3.705% 11/14/2022Armistice Capital LLC2,797,048$2.59M0.0%N/A4.546% 11/14/2022Altium Capital Management LP4,149,262$3.84M1.4%N/A6.744% 11/8/2022Apollon Wealth Management LLC48,790$45K0.0%N/A0.079% 11/7/2022Virtu Financial LLC46,168$43K0.0%+195.6%0.075% 10/13/2022PVG Asset Management Corp47,860$44K0.2%N/A0.100% 7/22/2022Geneos Wealth Management Inc.41,450$53K0.0%+25.8%0.087% 5/13/2022Parkman Healthcare Partners LLC270,665$463K0.1%-36.9%0.568% 2/9/2022Geneos Wealth Management Inc.28,950$59K0.0%+63.1%0.061% 2/4/2022Envestnet Asset Management Inc.122,224$249K0.0%+184.7%0.256% 2/2/2022PVG Asset Management Corp160,360$327K1.2%+109.6%0.336% 1/28/2022ARK Investment Management LLC1,059,722$2.16M0.0%-1.3%2.223% 11/16/2021Schonfeld Strategic Advisors LLC12,100$33K0.0%N/A0.025% 11/16/2021Intellectus Partners LLC28,500$78K0.0%-29.6%0.060% 11/12/2021Parkman Healthcare Partners LLC411,060$1.13M0.3%-44.0%0.869% 11/10/2021PVG Asset Management Corp76,510$210K0.6%N/A0.162% 10/26/2021Game Plan Financial Advisors LLC25,000$69K0.0%-13.8%0.053% 9/17/2021Virtu Financial LLC16,578$47K0.0%N/A0.035% 8/13/2021Renaissance Technologies LLC77,808$219K0.0%-84.6%0.165% 8/11/2021Susquehanna Fundamental Investments LLC19,026$53K0.0%-74.5%0.040% 8/9/2021Cutter & CO Brokerage Inc.18,667$52K0.0%-34.9%0.039% 5/18/2021Morgan Stanley398,412$1.11M0.0%-45.6%0.875% 5/18/2021First Heartland Consultants Inc.10,000$28K0.0%N/A0.023% 5/18/2021Silverarc Capital Management LLC200,000$558K0.3%N/A0.465% 5/17/2021Schonfeld Strategic Advisors LLC76,500$213K0.0%+115.5%0.178% 5/17/2021Intellectus Partners LLC40,500$113K0.0%N/A0.094% 5/17/2021Goldman Sachs Group Inc.16,621$46K0.0%N/A0.039% 5/13/2021Renaissance Technologies LLC505,121$1.41M0.0%+89.2%1.174% Trump Treasure April 19 (Ad)Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly that, just 12 months later…If I’m right about this (like I was before) a modest $900 investment…4/28/2021Game Plan Financial Advisors LLC26,000$74K0.0%N/A0.061% 2/12/2021LPL Financial LLC42,876$108K0.0%+154.1%0.111% 2/10/2021Rhumbline Advisers14,208$36K0.0%N/A0.037% (Data available from 1/1/2016 forward)Remove Ads BLRX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BLRX shares? During the previous two years, 11 institutional investors and hedge funds held shares of BioLineRx. The most heavily invested institutionals were Altium Capital Management LP ($2.02M), CVI Holdings LLC ($462K), Highbridge Capital Management LLC ($215K), Values First Advisors Inc. ($88K), Geneos Wealth Management Inc. ($74K), Atria Investments Inc ($72K), and Rathbones Group PLC ($72K).Learn more on BLRX's institutional investors. What percentage of BioLineRx stock is owned by institutional investors? 1.56% of BioLineRx stock is owned by institutional investors. Learn more on BLRX's institutional investor holdings. Which institutional investors have been buying BioLineRx stock? Of the 10 institutional investors that purchased BioLineRx stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Highbridge Capital Management LLC ($1.01M), CVI Holdings LLC ($815.68K), PVG Asset Management Corp ($185.42K), Values First Advisors Inc. ($48.35K), Rathbones Group PLC ($39.82K), Atria Investments Inc ($29.19K), and Allen Mooney & Barnes Investment Advisors LLC ($25K). How much institutional buying is happening at BioLineRx? Institutional investors have bought a total of 2,197,601 shares in the last 24 months. This purchase volume represents approximately $45.85M in transactions. Which BioLineRx major shareholders have been selling company stock? The following institutional investors have sold BioLineRx stock in the last 24 months: Altium Capital Management LP ($823.98K), and PVG Asset Management Corp ($66.89K). How much institutional selling is happening at BioLineRx? Institutional investors have sold a total of 890,863 shares in the last 24 months. This volume of shares sold represents approximately $33.49M in transactions. Related Companies KZR Institutional Ownership SPRO Institutional Ownership CELU Institutional Ownership CNTB Institutional Ownership DTIL Institutional Ownership ICCC Institutional Ownership LTRN Institutional Ownership KALA Institutional Ownership BRNS Institutional Ownership XLO Institutional Ownership This page (NASDAQ:BLRX) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredIs Fort Knox Hiding Less Gold Than We Think? Find Out What That Means for YouWith gold prices recently soaring to record highs over $3,000 an ounce, and central banks rushing to accumulat...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLineRx Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioLineRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.